Report Detail
Global Peptide Therapeutics Market Growth 2019-2024
- RnM3064894 |
- 06 March, 2019 |
- Global |
- 163 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another. Peptides are distinguished from proteins on the basis of size, and as a benchmark can be understood to contain approximately 50 amino acids or less.
In this report, we study the peptide-based drugs.
In the last several years, global market of Peptide Therapeutics developed rapidly, with an average growth rate of 7.7%. The major factors that are driving the growth of this market are the rising prevalence of metabolic disorders and the increasing pool of cancer patients. The technological advancements, resulting in a significant reduction in the production cost of peptide drugs, is also boosting this market remarkably. In 2017, global revenue of Peptide Therapeutics is nearly 28.5 billion USD; the actual production is about 150 million units.
The classification of Peptide Therapeutics includes Injection, Oral and other, and the proportion of Injection in 2017 is about 74.2%, and the proportion is decreasing trend from 2013 to 2018.
Peptide Therapeutics is widely sales for Cancer, Metabolic Disorders, Central Nervous System and Others. The key application of peptide therapeutics is into cancer mainly used for treating prostrate, pancreatic, ovarian, and breast cancer. and the consumption proportion is about 33.6% in 2017.
According to this study, over the next five years the Peptide Therapeutics market will register a 5.5% CAGR in terms of revenue, the global market size will reach US$ 39300 million by 2024, from US$ 28500 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Peptide Therapeutics business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Peptide Therapeutics market by product type, application, key manufacturers and key regions and countries.
This study considers the Peptide Therapeutics value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Injection
Oral
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Cancer
Metabolic Disorders
Central Nervous System
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
Shire
AbbVie
Ipsen
Allergan
Ferring
Merck
The Medicines
Roche
J & J
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Peptide Therapeutics consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Peptide Therapeutics market by identifying its various subsegments.
Focuses on the key global Peptide Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Peptide Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Peptide Therapeutics submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Peptide Therapeutics Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Peptide Therapeutics Consumption 2014-2024
- 2.1.2 Peptide Therapeutics Consumption CAGR by Region
- 2.2 Peptide Therapeutics Segment by Type
- 2.2.1 Injection
- 2.2.2 Oral
- 2.2.3 Other
- 2.3 Peptide Therapeutics Consumption by Type
- 2.3.1 Global Peptide Therapeutics Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Peptide Therapeutics Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Peptide Therapeutics Sale Price by Type (2014-2019)
- 2.4 Peptide Therapeutics Segment by Application
- 2.4.1 Cancer
- 2.4.2 Metabolic Disorders
- 2.4.3 Central Nervous System
- 2.4.4 Other
- 2.5 Peptide Therapeutics Consumption by Application
- 2.5.1 Global Peptide Therapeutics Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Peptide Therapeutics Value and Market Share by Application (2014-2019)
- 2.5.3 Global Peptide Therapeutics Sale Price by Application (2014-2019)
3 Global Peptide Therapeutics by Players
- 3.1 Global Peptide Therapeutics Sales Market Share by Players
- 3.1.1 Global Peptide Therapeutics Sales by Players (2017-2019)
- 3.1.2 Global Peptide Therapeutics Sales Market Share by Players (2017-2019)
- 3.2 Global Peptide Therapeutics Revenue Market Share by Players
- 3.2.1 Global Peptide Therapeutics Revenue by Players (2017-2019)
- 3.2.2 Global Peptide Therapeutics Revenue Market Share by Players (2017-2019)
- 3.3 Global Peptide Therapeutics Sale Price by Players
- 3.4 Global Peptide Therapeutics Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Peptide Therapeutics Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Peptide Therapeutics Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Peptide Therapeutics by Regions
- 4.1 Peptide Therapeutics by Regions
- 4.1.1 Global Peptide Therapeutics Consumption by Regions
- 4.1.2 Global Peptide Therapeutics Value by Regions
- 4.2 Americas Peptide Therapeutics Consumption Growth
- 4.3 APAC Peptide Therapeutics Consumption Growth
- 4.4 Europe Peptide Therapeutics Consumption Growth
- 4.5 Middle East & Africa Peptide Therapeutics Consumption Growth
5 Americas
- 5.1 Americas Peptide Therapeutics Consumption by Countries
- 5.1.1 Americas Peptide Therapeutics Consumption by Countries (2014-2019)
- 5.1.2 Americas Peptide Therapeutics Value by Countries (2014-2019)
- 5.2 Americas Peptide Therapeutics Consumption by Type
- 5.3 Americas Peptide Therapeutics Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Peptide Therapeutics Consumption by Countries
- 6.1.1 APAC Peptide Therapeutics Consumption by Countries (2014-2019)
- 6.1.2 APAC Peptide Therapeutics Value by Countries (2014-2019)
- 6.2 APAC Peptide Therapeutics Consumption by Type
- 6.3 APAC Peptide Therapeutics Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Peptide Therapeutics by Countries
- 7.1.1 Europe Peptide Therapeutics Consumption by Countries (2014-2019)
- 7.1.2 Europe Peptide Therapeutics Value by Countries (2014-2019)
- 7.2 Europe Peptide Therapeutics Consumption by Type
- 7.3 Europe Peptide Therapeutics Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Peptide Therapeutics by Countries
- 8.1.1 Middle East & Africa Peptide Therapeutics Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Peptide Therapeutics Value by Countries (2014-2019)
- 8.2 Middle East & Africa Peptide Therapeutics Consumption by Type
- 8.3 Middle East & Africa Peptide Therapeutics Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Peptide Therapeutics Distributors
- 10.3 Peptide Therapeutics Customer
11 Global Peptide Therapeutics Market Forecast
- 11.1 Global Peptide Therapeutics Consumption Forecast (2019-2024)
- 11.2 Global Peptide Therapeutics Forecast by Regions
- 11.2.1 Global Peptide Therapeutics Forecast by Regions (2019-2024)
- 11.2.2 Global Peptide Therapeutics Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Peptide Therapeutics Forecast by Type
- 11.8 Global Peptide Therapeutics Forecast by Application
12 Key Players Analysis
- 12.1 Sanofi
- 12.1.1 Company Details
- 12.1.2 Peptide Therapeutics Product Offered
- 12.1.3 Sanofi Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Sanofi News
- 12.2 Teva
- 12.2.1 Company Details
- 12.2.2 Peptide Therapeutics Product Offered
- 12.2.3 Teva Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Teva News
- 12.3 Novo Nordisk
- 12.3.1 Company Details
- 12.3.2 Peptide Therapeutics Product Offered
- 12.3.3 Novo Nordisk Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Novo Nordisk News
- 12.4 Takeda
- 12.4.1 Company Details
- 12.4.2 Peptide Therapeutics Product Offered
- 12.4.3 Takeda Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Takeda News
- 12.5 Eli Lilly
- 12.5.1 Company Details
- 12.5.2 Peptide Therapeutics Product Offered
- 12.5.3 Eli Lilly Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Eli Lilly News
- 12.6 AstraZeneca
- 12.6.1 Company Details
- 12.6.2 Peptide Therapeutics Product Offered
- 12.6.3 AstraZeneca Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 AstraZeneca News
- 12.7 Novartis
- 12.7.1 Company Details
- 12.7.2 Peptide Therapeutics Product Offered
- 12.7.3 Novartis Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Novartis News
- 12.8 Shire
- 12.8.1 Company Details
- 12.8.2 Peptide Therapeutics Product Offered
- 12.8.3 Shire Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Shire News
- 12.9 AbbVie
- 12.9.1 Company Details
- 12.9.2 Peptide Therapeutics Product Offered
- 12.9.3 AbbVie Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 AbbVie News
- 12.10 Ipsen
- 12.10.1 Company Details
- 12.10.2 Peptide Therapeutics Product Offered
- 12.10.3 Ipsen Peptide Therapeutics Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Ipsen News
- 12.11 Allergan
- 12.12 Ferring
- 12.13 Merck
- 12.14 The Medicines
- 12.15 Roche
- 12.16 J & J
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Peptide Therapeutics . Industry analysis & Market Report on Peptide Therapeutics is a syndicated market report, published as Global Peptide Therapeutics Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Peptide Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
